Diffuse Myocardial Fibrosis in Dilated Cardiomyopathy: Risk Marker, Risk Factor, or Does it Matter? [0.03%]
弥漫性心肌纤维化在扩张型心肌病中的意义：风险标志物、危险因素或无关紧要？
Jonathan F Plehn,Robert W W Biederman
Jonathan F Plehn
Congenitally Corrected Transposition of the Great Arteries: Untangling the Mechanisms of Right Ventricular Dysfunction [0.03%]
大动脉转位的先天性矫正术后的右心室功能障碍机制解析
Candice K Silversides,S Lucy Roche
Candice K Silversides
Coronary Artery Calcium for Risk Stratification of Sudden Cardiac Death: The Coronary Artery Calcium Consortium [0.03%]
冠脉钙化评分用于猝死的风险分层：冠脉钙化联盟项目
Alexander C Razavi,S M Iftekhar Uddin,Zeina A Dardari et al.
Alexander C Razavi et al.
Background: Coronary artery calcium (CAC) is a marker of plaque burden. Whether CAC improves risk stratification for incident sudden cardiac death (SCD) beyond atherosclerotic cardiovascular disease (ASCVD) risk factors i...
More Than Meets the Eye: Cardiac Magnetic Resonance Image Entropy and Ventricular Arrhythmia Risk Prediction [0.03%]
超出常规：心脏磁共振图像熵与心室性心动过速风险预测关系初探
Katherine C Wu,Jonathan Chrispin
Katherine C Wu
Cardiovascular Imaging for Ischemic Heart Disease in Women: Time for a Paradigm Shift [0.03%]
女性缺血性心脏病的心血管影像学：是时候改变观念了
Patricia F Rodriguez Lozano,Elona Rrapo Kaso,Jamieson M Bourque et al.
Patricia F Rodriguez Lozano et al.
Heart disease is the leading cause of death among men and women. Women have a unique phenotype of ischemic heart disease with less calcified lesions, more nonobstructive plaques, and a higher prevalence of microvascular disease compared wit...
American Society of Echocardiography Algorithm for Degenerative Mitral Regurgitation: Comparison With CMR [0.03%]
美国超声心动图学会退行性二尖瓣反流算法与CMR的对比研究
Seth Uretsky,Islamiyat Babs Animashaun,Sakul Sakul et al.
Seth Uretsky et al.
Objectives: The purpose of this study was to compare the American Society of Echocardiography (ASE) algorithm for assessing mitral regurgitation (MR) to cardiac magnetic resonance (CMR) and left ventricular (LV) remodelin...
Defining "Better Prediction" by Machine-Learning Models Toward Clinical Application [0.03%]
从预测性能定义机器学习模型的临床应用价值
Rikuta Hamaya,Yuki Sahashi,Nobuyuki Kagiyama
Rikuta Hamaya
Partho P Sengupta,Y Chandrashekhar
Partho P Sengupta
Another Step Toward Integrated MR/PET as Favored Imaging Modality in Cardiac Sarcoidosis [0.03%]
心脏淋巴瘤首选影像模态的集成MR/PET又近一步
Thomas H Schindler,Ines Valenta
Thomas H Schindler
Risk Stratification by CMR After STEMI: Is it Time to Drop the Gadolinium? [0.03%]
超急性和急性ST段抬高型心肌梗死后的CMR风险分层：放弃使用钆剂的时候来了吗？
Martin Reindl,Sebastian J Reinstadler
Martin Reindl